Gelesis (CPSR) Income Statement (2020 - 2023)
Income Statement report data from Sep 30, 2020 to Jun 30, 2023 for Gelesis (CPSR).
Reported currency: USD
| Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Sep 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||
Total Revenue | 1.11M (-36.57%) | 1.75M (-33.46%) | 2.63M (-60.45%) | 6.65M (-25.86%) | 8.97M (+19.44%) | 7.51M (+159.86%) | 2.89M (-3.99%) | 3.01M (+38.07%) | 2.18M (-29.68%) | 3.10M | - |
Cost Of Revenue | 500K (-59.68%) | 1.24M (-91.29%) | 14M (+293.37%) | 3.62M (-24.43%) | 4.79M (-2.44%) | 4.91M (+104.58%) | 2.40M (-13.04%) | 2.76M (+37.31%) | 2.01M (-28.72%) | 2.82M | - |
Costof Goods And Services Sold | 500K (-59.68%) | 1.24M (-91.29%) | 14M (+293.37%) | 3.62M (-24.43%) | 4.79M (-2.44%) | 4.91M (+104.58%) | 2.40M (-13.04%) | 2.76M (+37.31%) | 2.01M (-28.72%) | 2.82M | - |
Gross Profit | 610K (+17.31%) | 520K | -11.61M | 3.04M (-27.45%) | 4.19M (+61.15%) | 2.60M (+430.61%) | 490K (+96.00%) | 250K (+47.06%) | 170K (-39.29%) | 280K | - |
Operating Expenses | |||||||||||
Research And Development | 2.58M (-29.12%) | 3.64M (+56.90%) | 2.32M (-31.16%) | 3.37M (-38.95%) | 5.52M (-25.51%) | 7.41M | -340.00K | 3.24M (-42.04%) | 5.59M (+27.63%) | 4.38M | - |
Selling General And Administrative | 7.46M (-10.01%) | 8.29M (-30.63%) | 12M (-29.83%) | 17M (-47.52%) | 32M (-13.95%) | 38M (+84.85%) | 20M (-17.51%) | 25M (+77.02%) | 14M (+16.90%) | 12M (+6538.89%) | 180K |
Operating Expenses | 11M (-15.05%) | 12M (-15.78%) | 15M (-29.25%) | 21M (-45.61%) | 39M (-15.63%) | 46M (+121.43%) | 21M (-27.69%) | 29M (+41.73%) | 20M (+19.18%) | 17M (+9283.33%) | 180K |
Depreciation And Amortization | 570K (0.00%) | 570K (0.00%) | 570K (0.00%) | 570K (0.00%) | 570K (0.00%) | 570K (0.00%) | 570K (0.00%) | 570K (0.00%) | 570K (0.00%) | 570K | - |
Operating Income | |||||||||||
Operating Income | -10.00M (-16.46%) | -11.97M (-54.73%) | -26.44M (+47.46%) | -17.93M (-47.80%) | -34.35M (-20.26%) | -43.08M (+114.01%) | -20.13M (-28.82%) | -28.28M (+41.68%) | -19.96M (+20.24%) | -16.60M (+9122.22%) | -180.00K |
EBITDA | -7.93M (-15.64%) | -9.40M (-62.08%) | -24.79M (+38.26%) | -17.93M (-46.25%) | -33.36M (-19.61%) | -41.50M (+122.76%) | -18.63M (-32.57%) | -27.63M (+49.43%) | -18.49M (+12.54%) | -16.43M (+9027.78%) | -180.00K |
Other Income / Expenses | |||||||||||
Interest Income | - | - | - | - | - | - | - | - | - | - | 100K |
Interest Expense | -560.00K (-37.08%) | -890.00K (+74.51%) | -510.00K (+218.75%) | -160.00K (-15.79%) | -190.00K (+46.15%) | -130.00K (-68.29%) | -410.00K (+13.89%) | -360.00K (+56.52%) | -230.00K (-36.11%) | -360.00K | - |
Net Interest Income | 560K (-37.08%) | 890K (+74.51%) | 510K (+218.75%) | 160K (-15.79%) | 190K (+35.71%) | 140K (-66.67%) | 420K (+16.67%) | 360K (+56.52%) | 230K (-36.11%) | 360K (+260.00%) | 100K |
Other Non Operating Income | 2.88M (-62.79%) | 7.74M (+93.02%) | 4.01M (+1.78%) | 3.94M (-82.12%) | 22M (-41.27%) | 38M (+2876.98%) | 1.26M | -2.09M (-54.07%) | -4.55M (+184.38%) | -1.60M (+7900.00%) | -20.00K |
Net Income | |||||||||||
Income Before Tax | -7.68M (+49.71%) | -5.13M (-77.63%) | -22.93M (+62.05%) | -14.15M (+13.11%) | -12.51M (+119.47%) | -5.70M (-70.45%) | -19.29M (-37.23%) | -30.73M (+24.21%) | -24.74M (+33.23%) | -18.57M (+18470.00%) | -100.00K |
Income Tax Expense | - | 20K (-95.83%) | 480K | - | - | - | - | - | - | 20K (+100.00%) | 10K |
Net Income From Continuing Operations | -7.68M (+49.13%) | -5.15M (-78.00%) | -23.41M (+65.44%) | -14.15M (+13.11%) | -12.51M (+119.47%) | -5.70M (-70.45%) | -19.29M (-37.23%) | -30.73M (+24.21%) | -24.74M (+33.08%) | -18.59M (+16800.00%) | -110.00K |
Net Income | -7.68M (+49.13%) | -5.15M (-78.00%) | -23.41M (+65.44%) | -14.15M (+13.11%) | -12.51M (+119.47%) | -5.70M (-70.45%) | -19.29M (-37.23%) | -30.73M (+24.21%) | -24.74M (+33.08%) | -18.59M (+16800.00%) | -110.00K |